IVDR stands for In Vitro Diagnostic Regulation, which is a set of rules governing in vitro diagnostic medical devices in the European Union. This regulation aims to ensure the safety and performance of diagnostic tests used outside the human body, such as blood tests, urine analysis, and genetic screening.
The IVDR establishes a new regulatory framework for manufacturers, importers, and distributors of in vitro diagnostic devices. It introduces stricter requirements for clinical evidence, post-market surveillance, and traceability of devices throughout the supply chain, enhancing patient safety and healthcare quality.
IVDR is crucial in clinical research as it directly impacts the development, validation, and use of diagnostic tests in clinical trials. It ensures that in vitro diagnostic devices used in research meet high standards of quality and reliability, which is essential for generating accurate and trustworthy clinical data.
Understanding IVDR is important for researchers and sponsors to navigate regulatory compliance and market access for new diagnostic technologies. It influences study design, data collection methods, and the overall conduct of clinical investigations involving in vitro diagnostic devices, particularly in the European Union.
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant